Issue 4, 2016

De novo design of helical peptides to inhibit tumor necrosis factor-α by disrupting its trimer formation

Abstract

A computational strategy was used to design helical peptides that can bind to tumor necrosis factor-α (TNFα) dimers to prevent active trimer formation. Three designed peptides showed TNFα inhibition at the cellular level. Chemical crosslinking and mass spectrometry studies verified that these peptides function by breaking TNFα trimers.

Graphical abstract: De novo design of helical peptides to inhibit tumor necrosis factor-α by disrupting its trimer formation

Supplementary files

Article information

Article type
Research Article
Submitted
29 Nov 2015
Accepted
21 Jan 2016
First published
22 Jan 2016

Med. Chem. Commun., 2016,7, 725-729

Author version available

De novo design of helical peptides to inhibit tumor necrosis factor-α by disrupting its trimer formation

Q. Shen, C. Zhang, H. Liu, Y. Liu, J. Cao, X. Zhang, Y. Liang, M. Zhao and L. Lai, Med. Chem. Commun., 2016, 7, 725 DOI: 10.1039/C5MD00549C

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Spotlight

Advertisements